Update your location to show providers, locations, and services closest to you.
Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)
This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary Fibrosis (IPF) can join the study. If they already take nintedanib, they can continue…
This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older. If they already take nintedanib or pirfenidone for their IPF, they can continue treatment…
This randomized, double-blind, placebo matched to efzofitimod-controlled, study will evaluate the safety, tolerability, immunogenicity, pharmacokinetic (PK), and preliminary efficacy of multiple ascending doses of IV efzofitimod in participants with…
28 publications
2022
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
PubMed • Publisher's site2022
BMJ open respiratory research
PubMed • Publisher's site2022
American journal of respiratory and critical care medicine
PubMed • Publisher's site2021
Chest
PubMed • Publisher's site2021
Lung
PubMed • Publisher's site